RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
EpicentRx, Inc.
EpicentRx, Inc.
Advaxis, Inc.
National Cancer Institute (NCI)
Mayo Clinic
Chonnam National University Hospital
Emory University
Sunesis Pharmaceuticals
AHS Cancer Control Alberta
AHS Cancer Control Alberta
AHS Cancer Control Alberta
HealthPartners Institute
Valerio Therapeutics
Valerio Therapeutics
Bayer
SCRI Development Innovations, LLC
SCRI Development Innovations, LLC
SCRI Development Innovations, LLC
Astellas Pharma Inc